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Abstract 
Purpose: To evaluate the application of bacterial liposomes and archaeosomes as a novel drug 
delivery system for in vitro cytoplasmic delivery of molecules into cancer cells. 
Methods: Bacterial membrane lipids were extracted using chloroform and methanol. Bacterial 
liposomes and archaeosomes of E. coli, Acidianus brierleyi and Sulfolobus acidocaldarius were 
prepared using film method and their trailing in cancer cells (HT-29) was evaluated by 
carboxyfluorescein (CF). Their morphological characteristics were assessed by atomic force microscopy 
(AFM).  
Results: At 37 °C, the liposomes and archaeosomes interacted with cell membranes predominantly by 
fusion and endocytosis. The AFM images showed uniform and dispersed distribution of the liposomes. 
Conclusion: The findings demonstrate that bacterial liposomes and archaeosomes may be useful as 
drug delivery carriers for the treatment of cancer.  
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Cancer includes a heterogeneous array of 
malignant diseases which are characterized by 
unregulated proliferation of aberrant cells. 
Despite significant advances in screening and 
treatments, it is still the second leading cause of 
mortality. Chemotherapy is one of the common 
approaches for cancer treatment. However, it 
lacks selective targeting of proliferating cancer 
cells and thus both tumor and healthy cells are 
killed. Nano- carriers have been investigated for 
enhancing the efficacy and decreasing the side 
effects of therapeutic agents and many nano-
drug delivery systems have been successfully 
developed for these purposes [1].  
 
Liposomes are spherical vesicles with concentric 
phospholipid bilayers that can act as bio-
compatible, biodegradable and non-
immunogenic drug carriers [2]. The advantages 
of nano-carriers are their ability to entrap both 
lipophilic and hydrophilic drugs, selective delivery 
of entrapped drug to the targeted site, protecting 
encapsulated agents from metabolic processes, 
improved therapeutic indices, and increased 
circulation life times of the drug [2]. Despite 
worldwide interest in therapeutic applications of 
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liposomes in biotechnology, their preparation 
remains as a challenging issue [3]. Liposomes 
can be prepared from synthetic lipids such as 
dioleoylphosphatidylcholine or natural 
phospholipids (egg or soya) [4]. Although these 
preparations are very useful, they are expensive 
and commercially available from limited sources 
worldwide [3].  
 
Several studies have attempted to develop an 
alternative for synthetic liposomes. One of these 
approaches is to use bacterial lipid membranes. 
Although conventional liposomes are unstable, 
have relatively short half- life  and highly 
expensive to produce on a large scale [4,5], the 
ease of access to microorganisms throughout the 
year and their ability to grow on various 
substrates, make bacterial lipids suitable 
candidates for liposome preparation [6].  
 
Archaeosomes are a new generation of 
liposomes that composed of one or more polar 
ether lipids extracted from Archaea or synthetic 
archaeal lipids. These microorganisms live under 
harsh conditions including high temperatures, 
high salinity, high pressures, and extreme pH 
[7,8]. The ether linkages are more stable than 
esters against oxidation and high temperature 
[9]. Accordingly, archaeosomes are more 
resistant under such conditions [7-9].  
 
The objective of this study was to explore the use 
of bacterial liposomes prepared by lipids 
extracted from Escherichia coli (E. coli) cultures, 
and archaeosomes made with lipids derived from 
A. brierleyi and S. acidocaldarius as vehicles for 




The freeze-dried sealed glass ampoule of E. coli 
(ATCC no. 25922) was obtained from the Iranian 
Research Organization for Science and 
Technology (Tehran, Iran). S. acidocaldarius and 
A. brierleyi were kindly donated by National 
Iranian Copper Industries Co. (Sarcheshmeh, 
Kerman, Iran). Dulbecco’s modified eagle’s 
medium (DMEM) and 5(6)- carboxyfluorescein 
(CF) were obtained from Sigma-Aldrich 
(Germany).  Fetal bovine serum (FBS) was 
purchased from Gibco, USA. HT-29 cells were 
obtained from Pasteur Institute of Iran (ATCC no. 
HTB-38). 
 
Preparation of liposomes and archaeosomes 
 
The lipid extraction of E. coli and Archaea was 
performed using 1/2 and 2/1 (v/v) mixtures of 
chloroform/methanol, respectively [3,10]. 
Liposomes and archaeosomes were prepared 
from the extracted lipid by thin film method. 
Briefly, 2 % CF was added to the extracted lipid 
solution and mixed. The mixture was evaporated 
in a rotary evaporator (Heidolph, Germany). 
When a thin film was formed in a round-bottom 
flask, it was hydrated with phosphate buffer (pH 
7.4). The suspension was vortexed for 30 min 
and then sonicated for 45 min [11]. Morphology 
of the samples was assessed by an atomic force 
microscope (AFM, JPK, Nanowizardz, Germany).  
 
Evaluation of liposome and archaeosome 
uptake by cancer cells 
 
HT-29 human colonic epithelial cells were grown 
at 37 °C, 5 % CO2 and 95 % relative humidity in 
DMEM supplemented with 10 % FBS, 1 % non-
essential amino acids, and 1 % penicillin-
streptomycin. One ml of CF loaded liposomal 
and archaeosomal suspension was added to 5 
mL of DMEM of which 1 mL was incubated with a 
monolayer of HT-29 cells at 37 °C for different 
times (15, 60 and 120 min). After incubation, the 
cells were washed 3 times with PBS and then 
observed with inverted microscope (Olympus, 




AFM images showed distinct and uniform 
particles (Fig 1) and particle size which were in 
the range of 35 to 200 nm (Fig. 2). Bacterial 
liposomes were able to pass the HT-29 cells 
within the first 15 min of incubation at 37 °C; and 
a decrease in the fluorescence signal is 
observed after 60 and 120 min. (Fig. 3b). The 
archaeosomes could enter the cells within 15 
and 60 min where fluorescence signal was 
clearly observed, whereas after 120 min, 
fluorescence signal decreased (Fig. 3b-e), The 
CF-loaded bacterial liposomes and 
archaeosomes were also incubated for the same 
times at 4 °C. At this temperature, the interaction 





The present study, we assessed the morphology 
of vesicles which are composed of bacterial and 
tetra-ether lipids by AFM images imaging. The 
AFM technique in the tapping and non-contact 
mode approaches allows the observation of the 
liposomal morphology without any sample 
manipulation such as labeling, staining, or 
fixation [14].  
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Figure 1: AFM images of liposomes 
 
 
  Figure 2: Particle distribution of E. coli-derived liposomes 
 
 
Figure 3: CF contaning liposomes and archaeosomes incubated with HT-29 cells for different time intervals at 
37 ̊C: a) Bacterial liposome after 15 min, b) Archaeosomes of A.brierleyi after 15 min, c) Archaeosomes of 
A.brierleyi after 60 min, d) Archaeosomes of S.acidocaldarius after 15 min, e) Archaeosomes of S.acidocaldarius 
after 60 min 
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The AFM images showed distinct uniform 
particles. It has been previously reported that 
liposomes can change their shape once 
deposited on mica and contact motion of the tip 
(tapping) of AFM eliminates lateral or shear 
forces which would deform or scrape the sample 
[14]. The HT-29 cells are suitable alternative 
models for studying the cell bypass transport 
pathway [15]. Therefore, they were employed for 
evolution of ability of bacterial liposomes and 
archaeosomes in delivery of CF to cancer cell. 
CF is a commonly used aqueous dye as 
fluorescent reporter [3]. The results showed that 
bacterial liposomes were able to pass the HT-29 
cells within the first 15 min of incubation at 37 °C, 
after which a decrease in the fluorescence signal 
was observed after 60 and 120 min. This 
phenomenon can be attributed to can be 
attributed to intracellular degradation of the 
liposomes, after uptake, resulting in dilution of 
the fluorescent dye, which in turn decreases the 
fluorescence signal [3]. These results are in 
agreement with the previous findings of a study 
where delivery of molecules to cancer cells was 
assessed by employing E. coli liposomes. They 
incubated CF-loaded liposomes as a drug model 
with HeLa cells at different time periods (15, 60 
and 120 min) [3]. It was reported that liposomes 
could uptake cells within the first 15 min of 
incubation, followed by a reduction of the 
fluorescence signal after 60 and 120 min. 
 
It was observed that archaeosomes could enter 
the cells within 15 and 60 min. as was signaled 
by a reduction in the fluorescence. However, 
after 120 min., showed a decrease in 
fluorescence. The results indicate that 
archaeosomes were more stable than bacterial 
liposomes in delivery of CF to cancer cells. The 
present findings are in agreement with the results 
of Gonzalez et al that prepared archaeosomes 
from total polar lipids of Halorubrum 
tebenquichense and trailed them in J774 cells 
(murine macrophages) using a hydrophilic dye 
pyranine (HPTS: 8-hydroxypyrene-1, 3, 6-
trisulfonic acid). Their results showed that the 
archaeosomes did not fuse or disrupt staying 
inside the phagosomes for at least 60 min [16]. 
However, our findings are not in agreement with 
Higa et al (2012) who evaluated cell uptake of 
HPTS-containing ultradeformable archaeosomes 
(UDA); a type of vesicles that made of soybean 
phosphatidylcholine, sodium cholate, and polar 
lipids from Halorubrum tebenquichense. The 
uptake of HPTS-labeled vesicles was followed in 
J774 cells for 5 h. In this period, J774 cells 
captured HPTS-UDA following a linear kinetics 
[17]. It was suggested that it is possible to 
achieve high stability for a long time drug delivery 
into cells by adding soybean phosphatidylcholine 
and sodium cholate during preparation of 
archaeosomes made from lipid extract of S. 
acidocaldarius and A. brierleyi.   
 
The findings suggest that uptake of the 
nanoparticles following their adsorption on 
cellular membrane, occurs by endocytosis. At 37 
°C, liposomes interact with cell membranes. At 
37 °C, liposomes interact with cell membranes 
predominantly by fusion and endocytosis [18]. 
The CF-loaded bacterial liposomes and 
archaeosomes were also incubated for the same 
times at 4 °C. Previous studies have reported 
negligible or no endocytotic activity in cells at this 
temperature [3]. These nano-systems are loosely 
associated with cells at this temperature. The 
results indicate that uptake of liposomes and 
archaeosomes by cells at 37 °C was faster than 
at 4 °C. These results support the study of Lee et 
al who studied the delivery of calcein (as a 
fluorescent dye) containing liposomes into 
cultured KB Cells (a human nasopharyngeal 
cancer cell line) via folate receptor-mediated 
endocytosis. They observed that folate-
conjugated liposomes are endocytosed only at 
37 oC, while, no cytoplasmic fluorescence was 
observed at 4 °C [19]. Furthermore, Gurnani et al 
(2004) reported that uptake of archaeosomes 
with a net negative surface charge by 
endocytosis may be mediated via recognition by 
the phosphatidylserine receptor [20]. Further 
investigations are needed to determine the exact 
mechanism of CF uptake. 
 
Liposomes can be formulated from bacterial 
lipids of E. coli [5]. The cytoplasmic membrane of 
the E. coli includes a high proportion (70 – 75 %) 
of phosphatidylethanolamine [21]. Therefore, it 
can be considered as suitable candidate for 
formulation of liposomes. Chauhan et al 
developed E. coli  membrane  lipid  vesicles  
(escheriosomes)  and  demonstrated  that  
escheriosomes  successfully  fuse  with  the  
plasma  membrane  of  macrophages, which 
leads to  effective  cytoplasmic delivery  of  
entrapped  antigen,  a  prerequisite  for  inducing  
CD8+T cell  response  against antigens [22]. The 
findings which are in line with previous reports 
suggest that phospholipids derived from E. coli 
membrane may be a good candidate for 
preparation of liposomes or escheriosomes as 
nano-carriers for both drug deliveries to the 
cancer cells and as adjuvant for vaccine delivery.  
Since autoclaving is one of the most effective de-
contamination methods, therefore, the ability to 
maintain vesicle integrity after autoclaving would 
be a desirable property for systemic use of 
liposomes. One approach for achieving this 
feature is the use of liposomes that are 
composed of ether lipids isolated from Archaea. 
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S. acidocaldarius thrives at temperatures range 
of 65 – 85 oC [23]. 
 
In our previous HPTLC analysis, we reported that 
more than 78 % of the bacterial cell membrane is 
composed of glycerol ether [13]. Brown et al 
investigated the stability of liposomes made from 
the lipid isolated from the thermoacidophilic 
archaeon S. acidocaldarius against autoclaving. 
According to their findings, archaeosomes were 
autoclavable as they could retain their size, 
morphology and most of the entrapped CF [23].  
 
The results of stability assessment showed high 
consistency with the study of Brown et al for 
exploring archaeosomes in biotechnological 
applications as drug delivery system for drugs, 
genes, or cancer imaging agents. An ideal vector 
in drug delivery should be highly efficient in 
delivering the drug in a target-specific manner, 
stable in vitro as well as in vivo, nontoxic and 
non-immunogenic [24]. Many in vivo studies 
involving intravenous, subcutaneous, and oral 
administration of archaeosomes have 
demonstrated that archaeosomes are safe 
molecules and nontoxic [25]. Further studies are 
needed to modify and improve the characteristics 
of bacterial liposomes and archaeosomes as 
drug delivery systems, followed by in vivo 
studies. Bacterial liposomes are readily disrupted 
at low pH in the gastrointestinal tract, thus to 
overcome this problem of instability, 
encapsulation of enteric-coated capsules will be 




Bacterial liposomes and archaeosomes can 
enhance drug delivery to cancer cells. Our 
findings showed higher efficacy of 
archaeosomes, compared with bacterial 
liposomes in delivering molecules through cancer 
cells. These lipid vesicles may be internalized by 
endocytotic pathways. Intracellular uptake is the 
main permeation mechanism and biodegradation 
of the liposomes and archaeosomes inside the 
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